|
|
FDADocs 5/9/2008 | 0 (0) | 109 | 0 | 0 | English
CDER Forum for International Drug Regulatory AuthoritiesSeptember 25-28, 2006CDER???s International ProgramJustina A. Molzon, M.S. Pharm., J.D. Associate Director for Inter... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 107 | 3 | 0 | English
GuidanceDrug Safety Information ??? FDA???s Communication to the PublicU.S. Department of...) March 2007 Drug SafetyGuidanceDrug Safety Information ??? FDA???s Communication to the Public ... more>>
FDADocs 5/5/2008 | 0 (0) | 106 | 3 | 0 | English
Vaccine Safety: An FDA PerspectiveKaren Midthun, M.D. Deputy Director Center for Biologics Evaluation and Research U.S. FDAAmerican Course on Drug Development and Regulatory Sciences Washington ... more>>
FDADocs 5/9/2008 | 0 (0) | 103 | 0 | 0 | English
Why is it important to know that all these medicines contain acetaminophen?Because too much can damage your liver.Acetaminophen is an active ingredient found in more than 600... ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 100 | 2 | 0 | English
What is the relationship between FDA's Quality System Regulation for Devices, Part 820, and ISO 9001:2000? FDA's Quality System Regulation Part 820, is harmonized with ISO 13485:1996, which is based ... more>>
ProfessionalDocument 8/10/2008 | 0 (0) | 98 | 0 | 0 | English
Watson Announces Limited Recall of Fentanyl Transdermal System Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that one lot of 75 mcg/hr Fentanyl Transdermal ... more>>
FDADocs 5/9/2008 | 0 (0) | 96 | 0 | 0 | English
MEMORANDUMDEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHDATE: FROM:October 12, 2005 ... ... more>>
FDADocs 5/9/2008 | 1 (1) | 92 | 2 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Rockville, MD 20857September 28, 2006Reference Number: Dear Aripiprazole ANDA Applicant: This letter i... ... more>>
FDADocs 5/9/2008 | 0 (0) | 89 | 0 | 0 | English
F D A F A c t s : t h e c e n t e r F o r D e v i c e s A n D r A D i o l o g i c A l h e A lt hCDRH: Ensuring the safety and effectiveness of medical devices and the safety of... ... more>>
FDADocs 5/9/2008 | 0 (0) | 89 | 1 | 0 | English
sNDA 20-726 FDA MEDICAL AND STATISTICAL ODAC REPORTDrug Name: Femara?? Letrozole tablets Applicant: Novartis Date Submitted: July 11, 2000 Date Received: July 12, 2000 Date of Review: November ... more>>
FDADocs 5/9/2008 | 0 (0) | 85 | 0 | 0 | English
DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCHFDA CLINICAL BRIEFING DOCUMENT FOR THE ONCOLOGIC DRUG ADVISORY ... more>>
FDADocs 5/5/2008 | 0 (0) | 77 | 1 | 0 | English
Case 8:03-cv-01663-RAL-MSSDocument 64Filed 09/14/2004Page 1 of 13UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION UNITED STATES OF AMERICA, Pl... ... more>>
FDADocs 5/9/2008 | 0 (0) | 77 | 1 | 0 | English
Judy Staffa, co-leads, presiding. PRESENT: SOLOMON IYASU JUDY STAFFA LANA PAULS GERALD DAL PAN FDA FDA ... more>>
FDADocs 5/9/2008 | 0 (0) | 76 | 0 | 0 | English
Attachment A ??? Recall Alert Information Submit the information listed below to the CRU and OE/DCMO via RES: ??? Product(s) Description ??? Codes ??? Recalling Firm ??? Short Reason for Recall ... more>>
FDADocs 5/5/2008 | 0 (0) | 76 | 3 | 0 | English
headingsModule 1 Administrative information1.1 Forms 1.1.1 Application form: FDA form 1571 1.1.2 Application form: FDA form 356h 1.1.3 User fee cover sheet: FDA form 3397 1.1.4 Annual report ... more>>
| | | |
| results / page 15/25/50 |
Page: 2 of 33
|
2...
|
|